|Disease Group:||Blood And Marrow Transplantation; Leukemia; Lymphoma; Pediatrics|
|Phase of Study:||Phase I|
Expanded Cord Blood T Cells
Total Body Irradiation
|Treatment Location:||Only at MDACC|
|Estimated Length of Stay in Houston:||Initial phase of treatment: 30 - 50 days in the inpatient unit.|
Patients will be followed out patient after discharge. Readmission may be
Patients are expected to remain in Houston for 4 - 6 months.
|Return Visit:||After the first 100 days (+/-3 days), every 3 months (+/-1 week) during the |
first year, and then annually (+/-1 week) while the subject is on the study.
Patients will be considered on study for up to 5 yrs. unless a criterion for
removal is met.
|Home Care:||If needed, parental nutrition, antibiotic, IV fluids and antiemetics may be |
given at home.